Chemo-Induced Peripheral Neuropathy

NIH Award Will Support Research by Sandra Rieger, Ph.D., on Nerve Damage Induced by Cancer Chemotherapy  BAR HARBOR, MAINE — The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes of Health (NIH), to study the molecular …

MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy Read More »

This past August, 2016, The National Institutes of Health (NIH) provided two separate grants supporting peripheral neuropathy research last month. This is excellent news as it demonstrates recognition of the need for funding in this area. MDI Biological Laboratory Conducting Peripheral Neuropathy Research The MDI Biological Laboratory has announced that it has received a grant …

NIH Provides Two Grants for Peripheral Neuropathy Research Read More »

Genetic Bio Marker may Predict Chemo-Induced Peripheral Neuropathy Side Effects Associated with Prostate Cancer Treatment New study finds genetic alterations in the VAC14 gene are associated with an increased risk of chemo-induced peripheral neuropathy in prostate cancer patients. Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, …

Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker Read More »

Dr. Noah Kolb, MD of the University of Utah (a consortium partner of the Foundation’s for Peripheral Neuropathy Research Registry) presented results at the recent American Neurological Association 2015 Annual Meeting that indicated that as many as 50% of patients undergoing chemotherapy for cancer experience chemotherapy-induced peripheral neuropathy, but most cases go undiagnosed and are …

Chemotherapy-Induced Peripheral Neuropathy Common, but Underdiagnosed Read More »